Manoj Pandey

Dr. Manoj Pandey

Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, UP, India
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2020 in Neurological Sciences
Verified
Journal Article
Open access
PDF file
TFT. T. Favas
T. T. Favas
PDPriya Dev
Priya Dev
RCRameshwar Nath Chaurasia
Rameshwar Nath Chaurasia
KCKamlesh Chakravarty
Kamlesh Chakravarty
RMRahul Mishra
Rahul Mishra
APAbhishek Pathak
Abhishek Pathak
Background Coronaviruses mainly affect the respiratory system; however, there are reports of SARS-CoV and MERS-CoV causing neurological manifestations. We aimed at discussing the various neurological manifestations of SARS-CoV-2 infection and to estimate the prevalence of each of them. Methods We searched the following electronic databases; PubMed, MEDLINE, Scopus, EMBASE, Google Scholar, EBSCO, Web of Science, Cochrane Library, WHO database, and ClinicalTrials.gov. Relevant MeSH terms for COVID-19 and neurological manifestations were used. Randomized controlled trials, non-randomized controlled trials, case-control studies, cohort studies, cross-sectional studies, case series, and case reports were included in the study. To estimate the overall proportion of each neurological manifestations, the study employed meta-analysis of proportions using a random-effects model. Results Pooled prevalence of each neurological manifestations are, smell disturbances (35.8%; 95% CI 21.4–50.2), taste disturbances (38.5%; 95%CI 24.0–53.0), myalgia (19.3%; 95% CI 15.1–23.6), headache (14.7%; 95% CI 10.4–18.9), dizziness (6.1%; 95% CI 3.1–9.2), and syncope (1.8%; 95% CI 0.9–4.6). Pooled prevalence of acute cerebrovascular disease was (2.3%; 95%CI 1.0–3.6), of which majority were ischaemic stroke (2.1%; 95% CI 0.9–3.3), followed by haemorrhagic stroke (0.4%; 95% CI 0.2–0.6), and cerebral venous thrombosis (0.3%; 95% CI 0.1–0.6). Conclusions Neurological symptoms are common in SARS-CoV-2 infection, and from the large number of cases reported from all over the world daily, the prevalence of neurological features might increase again. Identifying some neurological manifestations like smell and taste disturbances can be used to screen patients with COVID-19 so that early identification and isolation is possible.

1 June 2012 in Surgical Oncology
Verified
Journal Article
Closed access
KJKumkum Jha
Kumkum Jha
MSMridula Shukla
Mridula Shukla
Manoj PandeyManoj Pandey
Manoj Pandey

1 May 2000 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
VSVijay K. Shukla
Vijay K. Shukla
HSHarbans Singh
Harbans Singh
Manoj PandeyManoj Pandey
Manoj Pandey
SUS.K. Upadhyay
S.K. Upadhyay
GNGopal Nath
Gopal Nath

26 September 2006 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
Manoj PandeyManoj Pandey
Manoj Pandey
GSGangadharan P Sarita
Gangadharan P Sarita
NDNandkumar Devi
Nandkumar Devi
BTBejoy C Thomas
Bejoy C Thomas
BHBadridien M Hussain
Badridien M Hussain
RKRita Krishnan
Rita Krishnan
Chemotherapy for cancer is an intense and cyclic treatment associated with number of side-effects. The present study evaluated the effect of chemotherapy on distress, anxiety and depression. A total of 117 patients were evaluated by using distress inventory for cancer (DIC2) and hospital anxiety and depression scale (HADS). Majority of the patients were taking chemotherapy for solid tumors (52; 44.4%). The mean distress score was 24, 18 (15.38%) were found to have anxiety while 19 (16.23%) had depression. High social status was the only factor found to influence distress while female gender was the only factor found to influence depression in the present study. The study highlights high psychological morbidity of cancer patients and influence of gender on depression. Construct of distress as evaluated by DIC 2 may have a possible overlap with anxiety.

1 October 2001 in Oral Oncology
Verified
Journal Article
Closed access
TST.T Sreelekha
T.T Sreelekha
KRK Ramadas
K Ramadas
Manoj PandeyManoj Pandey
Manoj Pandey
GTG Thomas
G Thomas
KNK.R Nalinakumari
K.R Nalinakumari
MPM.R Pillai
M.R Pillai

23 August 2004 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
Manoj PandeyManoj Pandey
Manoj Pandey
AMAleyamma Mathew
Aleyamma Mathew
EAElizabeth K. Abraham
Elizabeth K. Abraham
BRBalakrishnan Rajan
Balakrishnan Rajan